StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
GNLXGENELUX Corp
stockpulse.co.kr
Nasdaq
$2.01▼ 0.50%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $90.1MShares out 44.8M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

7
  • 9.2After-hours26.09.03 08:05
    4Ownership#●●●

    GENELUX Corp

    Joseph Cappello, an insider at Genelux Corp, filed a Form 4 report regarding a change in beneficial ownership of securities effective August 31, 2026. This filing serves as an official disclosure of executive stock holdings to the SEC.…more

    $2.01-0.50%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.2After-hours26.09.03 08:05
    4Ownership

    GENELUX Corp

    GENELUX Corp insider Thomas Zindrick filed a Form 4 on September 2, 2026, reporting changes in beneficial ownership of securities as of August 31, 2026. This filing serves as a standard disclosure of insider equity transactions.…more

    $2.01-0.50%vs prev close
    View filingShare
  • 9.2After-hours26.09.03 08:05
    4Ownership

    GENELUX Corp

    Insider Yu Yong has filed a Form 4 report regarding their beneficial ownership of Genelux Corp securities as of August 31, 2026. This filing serves to disclose changes in the insider's holdings.…more

    $2.01-0.50%vs prev close
    View filingShare

6 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.9After-hours26.09.10 05:01
    #●●●#●●●

    Genelux Reports Positive Case Study for Olvi-Vec in Small Cell Lung Cancer…more

    Genelux announced a case study where a small cell lung cancer patient showed significant tumor reduction and extended survival using Olvi-Vec combined with chemotherapy. As this is a single-patient report, further clinical data is required to confirm broader efficacy.…more

    $2.01-0.50%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 8.13After-hours26.08.14 05:20

    ●●●●●●●● ●●●●● ●●●●●●

    Genelux announced its second-quarter financial results and confirmed that topline data for its Phase 3 ovarian cancer trial of Olvi-Vec is expected in the second half of 2026. The company maintains a cash runway sufficient to fund operations through the first quarter of 2027 while advancing its lung cancer clinical programs.…more

    $2.01-0.50%vs prev close
    Read sourceShareGlobeNewswire

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →